• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Special Transfusion Situations

Anti-CD47 Interference with Serological Testing

Immunotherapy, the use of humanized monoclonal antibodies, is a promising therapy that works in conjunction with the patient’s own immune…

February 6, 2019

A New Drug for Patients with Thrombotic Thrombocytopenic Purpura

  Thrombotic thrombocytopenic purpura (TTP) is a rare disease in which autoimmune antibodies target ADAMTS13, a protease that cleaves the…

January 16, 2019

Whole Blood Transfusions on the Battlefield

Uncontrolled hemorrhage is life threatening for trauma victims, and transfusion of blood products along with hemorrhage control is critical for…

December 26, 2018

Older RBCs Associated with Increased Risk of Death Among Trauma Patients

Current regulations allow red blood cells (RBCs) to be stored and used for up to 42 days. During this time,…

November 27, 2018

Rituximab Treatment for Autoimmune Diseases

  Intravenous immune globin (IVIG) is used to treat immunoglobulin deficiency and autoimmune diseases.  However, other immune-modulating drugs, such as…

November 21, 2018

Eculizumab for Treating Cold Agglutinin Disease

Cold agglutinin disease (CAD) is a rare autoimmune disease caused by antibodies directed against red blood cell antigens, making them…

October 24, 2018

Red Cell Exchange for Patients with Sickle Cell Disease: an AABB Report

The Therapeutic Apheresis Subsection of the AABB, composed of 15 practicing apheresis physicians from 14 institutions, recently summarized how they…

September 12, 2018

Emicizumab Therapy for Hemophilia A

Treatment for hemophilia A usually involves intravenous injections of factor VIII multiple times a week. In 2012, emicizumab (a bispecific…

September 5, 2018

Plasma Transfusions in Trauma Patients with Short Transport Times

Since the US Food and Drug Administration may soon approve freeze-dried or lyophilized plasma, several trials have recently investigated the…

August 9, 2018

Plasma Transfused During Transport to Hospital Saves Lives in Trauma Patients

  Nearly 50,000 Americans die from severe injuries each year, mainly from severe hemorrhage within two hours after the injury….

July 31, 2018

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Interim pages omitted …
  • Page 14
  • Go to Next Page »

Primary Sidebar

Latest News

  • AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

  • Transfusion-related Alpha-Gal Syndrome

  • 2024 Serious Hazards of Transfusions (SHOT) Report in the U.K.

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley